Common use of INDs Clause in Contracts

INDs. Unless otherwise agreed in writing, Anesta shall have sole responsibility, by itself or through its Affiliates or Anesta Sub-Licensees, for applying for, updating and maintaining all INDs within the Territory and for ensuring that all requirements and conditions imposed upon the holder of such INDs are fully complied with at all times. However, upon the reasonable request of Anesta, ** Portions of the Exhibit have been omitted and have been filed separately pursuant to an application for confidential treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended. ImmuPharma shall provide reasonable assistance and cooperation in connection with such activities in relation to providing Technical Information requested by Anesta which is in ImmuPharma’s possession and Controlled by ImmuPharma and procuring that its staff, where necessary, attend regulatory hearings and are reasonably available to discuss matters specific to the Licensed Product. Anesta shall reimburse to ImmuPharma all reasonable costs and expenses, including without limitation all costs of materials, active ingredients and excipients, package, delivery and transport and the fair and proportional allocation of overhead costs of ImmuPharma’s personnel consistent with applicable IFRS.